Skip to content

Multi-center population pharmacokinetic study of intravenous vancomycin in adults in Hong Kong and development of web-based individual dose optimization interface

Multi-center population pharmacokinetic study of intravenous vancomycin in adults in Hong Kong and development of web-based individual dose optimization interface

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048714
Enrollment
Unknown
Registered
2021-07-13
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected or confirmed infection by methicillin-resistant staphylococcus aureus

Interventions

Case series:N/A

Sponsors

None listed

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) At least 18 years old; (2) Admitted to one of the following hospitals under Hospital Authority: Pamela Youde Nethersole Eastern Hospital, Ruttonjee and Tang Shiu Kin Hospitals, Queen Mary Hospital, Queen Elizabeth Hospital, Kwong Wah Hospital, United Christian Hospital, Prince of Wales Hospital, Princess Margaret Hospital, or Tuen Mun Hospital; and (3) prescribed intermittent intravenous vancomycin.

Exclusion criteria

Exclusion criteria: (1) Documented trypanophobia or hemophobia; (2) Subjects prescribed any form of renal replacement therapy to be started before or during IV vancomycin treatment.

Design outcomes

Primary

MeasureTime frame
Good predictive performance and stability of the developed popPK model;Proportion of subjects achieving the PK therapeutic target at any time point during treatment;Reduced proportion of subjects developing acute kidney injury;

Secondary

MeasureTime frame
Shortened time to achieving the pharmacokinetic therapeutic target;Shortened time to becoming afebrile;Shortened time to normalized white blood cell counts;Shortened duration of antibiotic treatment;Number of measurements of serum vancomycin concentration;

Countries

China

Contacts

Public ContactLAM Tai Ning Teddy

School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong

teddylam@cuhk.edu.hk+852 39436827

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026